Lifting Fibro Fog with Microdose Therapy™

Posted by

A man in a suit and tie appears deep in thought, with a contemplative expression on his face.

Fibromyalgia has multiple symptoms that significantly impact a patient’s quality of life—all-over muscle pain, fatigue, mood swings—but for many, fibro fog can be the most damaging to daily routines.

In this blog, we’ll examine what fibro fog is, what it feels like for people living with fibromyalgia, and how it impacts their daily lives. We’ll also dive into how Microdose Therapy™ can provide effective fibromyalgia pain relief treatment, delivering relief from fibro fog and other debilitating fibromyalgia symptoms.

The Everyday Weight of Fibro Fog

Fibro fog is a catch-all term that’s used to describe cognitive issues that patients with fibromyalgia experience regularly. The condition goes far beyond just being forgetful—fibro fog can make it hard to focus, find words to express ideas, remember details, or even think clearly. These symptoms can make patients think that something is wrong with them, or that their symptoms are “all in their heads,” but multiple studies have shown otherwise.

Research supports that cognitive dysfunction—the core of fibro fog—is a very real aspect of the condition, impacting memory, attention, and mental acuity.1 And for people living with fibromyalgia, fibro fog can be one of the most frustrating and challenging symptoms to contend with.

Fibro fog impacts everyday life directly, affecting work performance, social life, and day-to-day tasks like cooking, driving, or keeping track of appointments.1, 2 Patients describe it as unpredictable—as with many inflammatory diseases, some days are better than others—which can make it especially discouraging.2 Some patients have even reported that the mental fog they experience regularly is even more disruptive than the physical pain they experience.3

Finding Your Focus Again with Microdose Therapy™

The Helen Foundation’s signature Microdose Therapy™ has been conclusively proven as a safe and remarkably effective fibromyalgia symptom relief treatment. It helps eliminate fibro fog and other persistent symptoms quickly and effectively, allowing patients to reclaim their lives faster than other treatments can.

Microdose Therapy™ has been extensively studied and published in peer reviewed journals, and proven to be effective against a wide range of inflammatory conditions and diseases.Clinical studies have shown that patients with fibromyalgia experience a 77% average symptom improvement.4

As a treatment for chronic pain and fatigue, Microdose Therapy™ helps the body’s inflammatory response with minimal medication, reducing the risks of side effects while providing sustainable symptom relief. And for people suffering with fibromyalgia, having clarity restored quickly is nothing short of transformative.

For patients with inflammatory and autoimmune diseases, Microdose Therapy™ supplements the body’s decreasing cortisol production using regimens of cortisone tablets, a self-administered and safe pain management option.

This treatment is combined with other aspects of the program, such as patient-maintained pain diaries and a dedicated coach who provides tailored care guidance. With support every step of the way, Microdose Therapy™ restores control of pain management back to patients, offering a path to a symptom-free life much faster than traditional therapies.

If you’re ready to explore Microdose Therapy™ for fibromyalgia and clear away fibro fog, reach out to The Helen Foundation—contact us today to learn more and take the first step toward relief.

Sources

  1. Kratz, Anna L., et al. Fibrofog in Daily Life: An Examination of Ambulatory Subjective and Objective Cognitive Function in Fibromyalgia. Journal of Pain 21, no. 7–8 (2020): 855–866. https://pmc.ncbi.nlm.nih.gov/articles/PMC7153985
  2. Millar, Kayla A., Lyndsay Crump, and Diane L. LaChapelle. Lived Experiences of Cognitive Dysfunction in Fibromyalgia: How Patients Discuss Their Experiences and Suggestions for Patient Education. Journal of Patient Experience 11 (2024): Article 23743735241229385. https://pmc.ncbi.nlm.nih.gov/articles/PMC10851761
  3. Kravitz, Howard M., and Robert S. Katz. Fibrofog and Fibromyalgia: A Narrative Review and Implications for Clinical Practice. Rheumatology International 35, no. 7 (2015): 1115–1125. https://pubmed.ncbi.nlm.nih.gov/25583051/
  4. Irwin JB, Baldwin AL, Stenberg VI. General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity. J Inflamm Res. 2019;12:161-166 https://doi.org/10.2147/JIR.S195165